<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mirzayi, Chloe</style></author><author><style face="normal" font="default" size="100%">Renson, Audrey</style></author><author><style face="normal" font="default" size="100%">Zohra, Fatima</style></author><author><style face="normal" font="default" size="100%">Elsafoury, Shaimaa</style></author><author><style face="normal" font="default" size="100%">Geistlinger, Ludwig</style></author><author><style face="normal" font="default" size="100%">Kasselman, Lora J</style></author><author><style face="normal" font="default" size="100%">Eckenrode, Kelly</style></author><author><style face="normal" font="default" size="100%">van de Wijgert, Janneke</style></author><author><style face="normal" font="default" size="100%">Loughman, Amy</style></author><author><style face="normal" font="default" size="100%">Marques, Francine Z</style></author><author><style face="normal" font="default" size="100%">MacIntyre, David A</style></author><author><style face="normal" font="default" size="100%">Arumugam, Manimozhiyan</style></author><author><style face="normal" font="default" size="100%">Azhar, Rimsha</style></author><author><style face="normal" font="default" size="100%">Beghini, Francesco</style></author><author><style face="normal" font="default" size="100%">Bergstrom, Kirk</style></author><author><style face="normal" font="default" size="100%">Bhatt, Ami</style></author><author><style face="normal" font="default" size="100%">Bisanz, Jordan E</style></author><author><style face="normal" font="default" size="100%">Braun, Jonathan</style></author><author><style face="normal" font="default" size="100%">Bravo, Hector Corrada</style></author><author><style face="normal" font="default" size="100%">Buck, Gregory A</style></author><author><style face="normal" font="default" size="100%">Bushman, Frederic</style></author><author><style face="normal" font="default" size="100%">Casero, David</style></author><author><style face="normal" font="default" size="100%">Clarke, Gerard</style></author><author><style face="normal" font="default" size="100%">Collado, Maria Carmen</style></author><author><style face="normal" font="default" size="100%">Cotter, Paul D</style></author><author><style face="normal" font="default" size="100%">Cryan, John F</style></author><author><style face="normal" font="default" size="100%">Demmer, Ryan T</style></author><author><style face="normal" font="default" size="100%">Devkota, Suzanne</style></author><author><style face="normal" font="default" size="100%">Elinav, Eran</style></author><author><style face="normal" font="default" size="100%">Escobar, Juan S</style></author><author><style face="normal" font="default" size="100%">Fettweis, Jennifer</style></author><author><style face="normal" font="default" size="100%">Finn, Robert D</style></author><author><style face="normal" font="default" size="100%">Fodor, Anthony A</style></author><author><style face="normal" font="default" size="100%">Forslund, Sofia</style></author><author><style face="normal" font="default" size="100%">Franke, Andre</style></author><author><style face="normal" font="default" size="100%">Furlanello, Cesare</style></author><author><style face="normal" font="default" size="100%">Gilbert, Jack</style></author><author><style face="normal" font="default" size="100%">Grice, Elizabeth</style></author><author><style face="normal" font="default" size="100%">Haibe-Kains, Benjamin</style></author><author><style face="normal" font="default" size="100%">Handley, Scott</style></author><author><style face="normal" font="default" size="100%">Herd, Pamela</style></author><author><style face="normal" font="default" size="100%">Holmes, Susan</style></author><author><style face="normal" font="default" size="100%">Jacobs, Jonathan P</style></author><author><style face="normal" font="default" size="100%">Karstens, Lisa</style></author><author><style face="normal" font="default" size="100%">Knight, Rob</style></author><author><style face="normal" font="default" size="100%">Knights, Dan</style></author><author><style face="normal" font="default" size="100%">Koren, Omry</style></author><author><style face="normal" font="default" size="100%">Kwon, Douglas S</style></author><author><style face="normal" font="default" size="100%">Langille, Morgan</style></author><author><style face="normal" font="default" size="100%">Lindsay, Brianna</style></author><author><style face="normal" font="default" size="100%">McGovern, Dermot</style></author><author><style face="normal" font="default" size="100%">McHardy, Alice C</style></author><author><style face="normal" font="default" size="100%">McWeeney, Shannon</style></author><author><style face="normal" font="default" size="100%">Mueller, Noel T</style></author><author><style face="normal" font="default" size="100%">Nezi, Luigi</style></author><author><style face="normal" font="default" size="100%">Olm, Matthew</style></author><author><style face="normal" font="default" size="100%">Palm, Noah</style></author><author><style face="normal" font="default" size="100%">Pasolli, Edoardo</style></author><author><style face="normal" font="default" size="100%">Raes, Jeroen</style></author><author><style face="normal" font="default" size="100%">Redinbo, Matthew R</style></author><author><style face="normal" font="default" size="100%">Rühlemann, Malte</style></author><author><style face="normal" font="default" size="100%">Balfour Sartor, R</style></author><author><style face="normal" font="default" size="100%">Schloss, Patrick D</style></author><author><style face="normal" font="default" size="100%">Schriml, Lynn</style></author><author><style face="normal" font="default" size="100%">Segal, Eran</style></author><author><style face="normal" font="default" size="100%">Shardell, Michelle</style></author><author><style face="normal" font="default" size="100%">Sharpton, Thomas</style></author><author><style face="normal" font="default" size="100%">Smirnova, Ekaterina</style></author><author><style face="normal" font="default" size="100%">Sokol, Harry</style></author><author><style face="normal" font="default" size="100%">Sonnenburg, Justin L</style></author><author><style face="normal" font="default" size="100%">Srinivasan, Sujatha</style></author><author><style face="normal" font="default" size="100%">Thingholm, Louise B</style></author><author><style face="normal" font="default" size="100%">Turnbaugh, Peter J</style></author><author><style face="normal" font="default" size="100%">Upadhyay, Vaibhav</style></author><author><style face="normal" font="default" size="100%">Walls, Ramona L</style></author><author><style face="normal" font="default" size="100%">Wilmes, Paul</style></author><author><style face="normal" font="default" size="100%">Yamada, Takuji</style></author><author><style face="normal" font="default" size="100%">Zeller, Georg</style></author><author><style face="normal" font="default" size="100%">Zhang, Mingyu</style></author><author><style face="normal" font="default" size="100%">Zhao, Ni</style></author><author><style face="normal" font="default" size="100%">Zhao, Liping</style></author><author><style face="normal" font="default" size="100%">Bao, Wenjun</style></author><author><style face="normal" font="default" size="100%">Culhane, Aedin</style></author><author><style face="normal" font="default" size="100%">Devanarayan, Viswanath</style></author><author><style face="normal" font="default" size="100%">Dopazo, Joaquin</style></author><author><style face="normal" font="default" size="100%">Fan, Xiaohui</style></author><author><style face="normal" font="default" size="100%">Fischer, Matthias</style></author><author><style face="normal" font="default" size="100%">Jones, Wendell</style></author><author><style face="normal" font="default" size="100%">Kusko, Rebecca</style></author><author><style face="normal" font="default" size="100%">Mason, Christopher E</style></author><author><style face="normal" font="default" size="100%">Mercer, Tim R</style></author><author><style face="normal" font="default" size="100%">Sansone, Susanna-Assunta</style></author><author><style face="normal" font="default" size="100%">Scherer, Andreas</style></author><author><style face="normal" font="default" size="100%">Shi, Leming</style></author><author><style face="normal" font="default" size="100%">Thakkar, Shraddha</style></author><author><style face="normal" font="default" size="100%">Tong, Weida</style></author><author><style face="normal" font="default" size="100%">Wolfinger, Russ</style></author><author><style face="normal" font="default" size="100%">Hunter, Christopher</style></author><author><style face="normal" font="default" size="100%">Segata, Nicola</style></author><author><style face="normal" font="default" size="100%">Huttenhower, Curtis</style></author><author><style face="normal" font="default" size="100%">Dowd, Jennifer B</style></author><author><style face="normal" font="default" size="100%">Jones, Heidi E</style></author><author><style face="normal" font="default" size="100%">Waldron, Levi</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">Genomic Standards Consortium</style></author><author><style face="normal" font="default" size="100%">Massive Analysis and Quality Control Society</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Reporting guidelines for human microbiome research: the STORMS checklist.</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Med</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Nat Med</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Computational Biology</style></keyword><keyword><style  face="normal" font="default" size="100%">Dysbiosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Microbiota</style></keyword><keyword><style  face="normal" font="default" size="100%">Observational Studies as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Research Design</style></keyword><keyword><style  face="normal" font="default" size="100%">Translational Science, Biomedical</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2021 11</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">27</style></volume><pages><style face="normal" font="default" size="100%">1885-1892</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;The particularly interdisciplinary nature of human microbiome research makes the organization and reporting of results spanning epidemiology, biology, bioinformatics, translational medicine and statistics a challenge. Commonly used reporting guidelines for observational or genetic epidemiology studies lack key features specific to microbiome studies. Therefore, a multidisciplinary group of microbiome epidemiology researchers adapted guidelines for observational and genetic studies to culture-independent human microbiome studies, and also developed new reporting elements for laboratory, bioinformatics and statistical analyses tailored to microbiome studies. The resulting tool, called 'Strengthening The Organization and Reporting of Microbiome Studies' (STORMS), is composed of a 17-item checklist organized into six sections that correspond to the typical sections of a scientific publication, presented as an editable table for inclusion in supplementary materials. The STORMS checklist provides guidance for concise and complete reporting of microbiome studies that will facilitate manuscript preparation, peer review, and reader comprehension of publications and comparative analysis of published results.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">11</style></issue><custom1><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/34789871?dopt=Abstract</style></custom1></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Menden, Michael P</style></author><author><style face="normal" font="default" size="100%">Wang, Dennis</style></author><author><style face="normal" font="default" size="100%">Mason, Mike J</style></author><author><style face="normal" font="default" size="100%">Szalai, Bence</style></author><author><style face="normal" font="default" size="100%">Bulusu, Krishna C</style></author><author><style face="normal" font="default" size="100%">Guan, Yuanfang</style></author><author><style face="normal" font="default" size="100%">Yu, Thomas</style></author><author><style face="normal" font="default" size="100%">Kang, Jaewoo</style></author><author><style face="normal" font="default" size="100%">Jeon, Minji</style></author><author><style face="normal" font="default" size="100%">Wolfinger, Russ</style></author><author><style face="normal" font="default" size="100%">Nguyen, Tin</style></author><author><style face="normal" font="default" size="100%">Zaslavskiy, Mikhail</style></author><author><style face="normal" font="default" size="100%">Jang, In Sock</style></author><author><style face="normal" font="default" size="100%">Ghazoui, Zara</style></author><author><style face="normal" font="default" size="100%">Ahsen, Mehmet Eren</style></author><author><style face="normal" font="default" size="100%">Vogel, Robert</style></author><author><style face="normal" font="default" size="100%">Neto, Elias Chaibub</style></author><author><style face="normal" font="default" size="100%">Norman, Thea</style></author><author><style face="normal" font="default" size="100%">Tang, Eric K Y</style></author><author><style face="normal" font="default" size="100%">Garnett, Mathew J</style></author><author><style face="normal" font="default" size="100%">Veroli, Giovanni Y Di</style></author><author><style face="normal" font="default" size="100%">Fawell, Stephen</style></author><author><style face="normal" font="default" size="100%">Stolovitzky, Gustavo</style></author><author><style face="normal" font="default" size="100%">Guinney, Justin</style></author><author><style face="normal" font="default" size="100%">Dry, Jonathan R</style></author><author><style face="normal" font="default" size="100%">Saez-Rodriguez, Julio</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">AstraZeneca-Sanger Drug Combination DREAM Consortium</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Commun</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Nat Commun</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">ADAM17 Protein</style></keyword><keyword><style  face="normal" font="default" size="100%">Antineoplastic Combined Chemotherapy Protocols</style></keyword><keyword><style  face="normal" font="default" size="100%">Benchmarking</style></keyword><keyword><style  face="normal" font="default" size="100%">Biomarkers, Tumor</style></keyword><keyword><style  face="normal" font="default" size="100%">Cell Line, Tumor</style></keyword><keyword><style  face="normal" font="default" size="100%">Computational Biology</style></keyword><keyword><style  face="normal" font="default" size="100%">Datasets as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug Antagonism</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug Resistance, Neoplasm</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug Synergism</style></keyword><keyword><style  face="normal" font="default" size="100%">Genomics</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular Targeted Therapy</style></keyword><keyword><style  face="normal" font="default" size="100%">mutation</style></keyword><keyword><style  face="normal" font="default" size="100%">Neoplasms</style></keyword><keyword><style  face="normal" font="default" size="100%">pharmacogenetics</style></keyword><keyword><style  face="normal" font="default" size="100%">Phosphatidylinositol 3-Kinases</style></keyword><keyword><style  face="normal" font="default" size="100%">Phosphoinositide-3 Kinase Inhibitors</style></keyword><keyword><style  face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2019 06 17</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">2674</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven approaches to find optimal patient-specific treatments. Here we report AstraZeneca's large drug combination dataset, consisting of 11,576 experiments from 910 combinations across 85 molecularly characterized cancer cell lines, and results of a DREAM Challenge to evaluate computational strategies for predicting synergistic drug pairs and biomarkers. 160 teams participated to provide a comprehensive methodological development and benchmarking. Winning methods incorporate prior knowledge of drug-target interactions. Synergy is predicted with an accuracy matching biological replicates for &gt;60% of combinations. However, 20% of drug combinations are poorly predicted by all methods. Genomic rationale for synergy predictions are identified, including ADAM17 inhibitor antagonism when combined with PIK3CB/D inhibition contrasting to synergy when combined with other PI3K-pathway inhibitors in PIK3CA mutant cells.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><custom1><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/31209238?dopt=Abstract</style></custom1></record></records></xml>